Anaplastic Oligoastrocytoma - 21 Studies Found
| Active, not recruiting |
: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma :
|
| Active, not recruiting |
: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor :
|
| Active, not recruiting |
: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor :
|
| Completed |
: Sorafenib in Newly Diagnosed High Grade Glioma :
: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li |
| Terminated |
: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma :
|
| Completed |
: BIBF 1120 for Recurrent High-Grade Gliomas :
: Drug: BIBF 1120 200 mg BID oral for 28 day cycle |
| Terminated |
: Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols :
|
| Recruiting |
: WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas :
|
| Terminated |
: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma :
|
| Not yet recruiting |
: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children :
|